CASI Pharmaceuticals Statistics
Total Valuation
CASIF has a market cap or net worth of 2.65 million. The enterprise value is 39.38 million.
| Market Cap | 2.65M |
| Enterprise Value | 39.38M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CASIF has 20.56 million shares outstanding. The number of shares has increased by 28.73% in one year.
| Current Share Class | 20.56M |
| Shares Outstanding | 20.56M |
| Shares Change (YoY) | +28.73% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 20.93% |
| Owned by Institutions (%) | 12.36% |
| Float | 9.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.13 |
| PB Ratio | -0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.95 |
| Interest Coverage | -22.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -91.69% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 84.16% |
| Weighted Average Cost of Capital (WACC) | 3.92% |
| Revenue Per Employee | 93,991 |
| Profits Per Employee | -205,449 |
| Employee Count | 214 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 3.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.42% in the last 52 weeks. The beta is 1.40, so CASIF's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -94.42% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.52 |
| Relative Strength Index (RSI) | 47.29 |
| Average Volume (20 Days) | 2,971 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 15.86 |
Income Statement
In the last 12 months, CASIF had revenue of 20.11 million and -43.97 million in losses. Loss per share was -2.09.
| Revenue | 20.11M |
| Gross Profit | 12.06M |
| Operating Income | -38.34M |
| Pretax Income | -43.97M |
| Net Income | -43.97M |
| EBITDA | -37.62M |
| EBIT | -38.34M |
| Loss Per Share | -2.09 |
Balance Sheet
The company has 3.77 million in cash and 40.50 million in debt, with a net cash position of -36.73 million or -1.79 per share.
| Cash & Cash Equivalents | 3.77M |
| Total Debt | 40.50M |
| Net Cash | -36.73M |
| Net Cash Per Share | -1.79 |
| Equity (Book Value) | -58.27M |
| Book Value Per Share | -2.83 |
| Working Capital | -56.59M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -16,000 |
| Depreciation & Amortization | 720,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -20.77M |
| FCF Per Share | -1.01 |
Margins
Gross margin is 59.97%, with operating and profit margins of -190.59% and -218.58%.
| Gross Margin | 59.97% |
| Operating Margin | -190.59% |
| Pretax Margin | -218.58% |
| Profit Margin | -218.58% |
| EBITDA Margin | -187.01% |
| EBIT Margin | -190.59% |
| FCF Margin | n/a |
Dividends & Yields
CASIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.73% |
| Shareholder Yield | -28.73% |
| Earnings Yield | -1,660.60% |
| FCF Yield | -784.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jun 2, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
CASIF has an Altman Z-Score of -59.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -59.21 |
| Piotroski F-Score | 2 |